Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib”

525 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 525 results

Not applicableNot Yet RecruitingNCT07618546
What this trial is testing

A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors

Who this might be right for
HCC - Hepatocellular Carcinoma
Henan Cancer Hospital 208
Testing effectiveness (Phase 2)Study completedNCT06281886
What this trial is testing

Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaEfficacyToxicity
Sun Yat-sen University 170
Testing effectiveness (Phase 2)WithdrawnNCT03190239
What this trial is testing

Efficacy and Safety of Maintenance Apatinib Combined With Pemetrexed in Advanced Non-squamous Non-small Cell Lung Cancer Patients

Who this might be right for
Advanced Non-squamous Non-small-cell Lung Cancer
Xinqiao Hospital of Chongqing
Not applicableUnknownNCT04782622
What this trial is testing

The Combination of Apatinib and Camerlizumab for Advanced Lung Cancer Patients With Muti-line Therapy

Who this might be right for
Lung Cancer
The Affiliated Hospital of Qingdao University 60
Testing effectiveness (Phase 2)UnknownNCT04165174
What this trial is testing

PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT

Who this might be right for
HCC
Huazhong University of Science and Technology 20
Testing effectiveness (Phase 2)UnknownNCT05556200
What this trial is testing

A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs

Who this might be right for
Breast CancerTriple-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 58
Early research (Phase 1)UnknownNCT03645200
What this trial is testing

Treatment of Carrying TP53 Harmful Mutations

Who this might be right for
Advanced Cancer
Tianjin Medical University Second Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07773363
What this trial is testing

Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tang-Du Hospital 37
Large-scale testing (Phase 3)UnknownNCT03355612
What this trial is testing

XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma

Who this might be right for
Gastric Carcinoma
Tianjin Medical University Cancer Institute and Hospital 456
Testing effectiveness (Phase 2)UnknownNCT05225844
What this trial is testing

An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced Gastrointestinal

Who this might be right for
Gastrointestinal CancerImmunotherapyTargeted Therapy
Harbin Medical University 150
Testing effectiveness (Phase 2)UnknownNCT04878107
What this trial is testing

SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Wuhan University 88
Testing effectiveness (Phase 2)Study completedNCT04625803
What this trial is testing

Neoadjuvant Therapy for Locally Advanced Colon Cancer

Who this might be right for
Colon CancerNeoadjuvant Therapy
Zhejiang University 64
Testing effectiveness (Phase 2)Looking for participantsNCT06831175
What this trial is testing

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

Who this might be right for
Adrenal Cortical CarcinomaAdrenal Cortical CancerAdrenal Cancer
West China Hospital 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06339216
What this trial is testing

A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)UnknownNCT02544737
What this trial is testing

Apatinib for Metastatic Esophageal Cancer.

Who this might be right for
Esophageal CancerMetastatic Esophageal CancerApatinib
Hangzhou Cancer Hospital 29
Large-scale testing (Phase 3)Looking for participantsNCT06172205
What this trial is testing

Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC

Who this might be right for
BCLC Stage C Hepatocellular CarcinomaChemotherapy Effect
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 262
Large-scale testing (Phase 3)UnknownNCT04000295
What this trial is testing

Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd. 280
Testing effectiveness (Phase 2)UnknownNCT03707639
What this trial is testing

Study of the Combination of Apatinib and POF

Who this might be right for
Gastric Adenocarcinoma
Fujian Cancer Hospital 26
Testing effectiveness (Phase 2)Study completedNCT05156970
What this trial is testing

Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 81
Testing effectiveness (Phase 2)Looking for participantsNCT07464756
What this trial is testing

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 80
Next Page